Alison BondDirector, Global Regulatory Policy & Intelligence at Janssen, UK
Alison has worked within academic, CRO and pharmaceutical company environments throughout her career, holding technical and leadership roles across various R&D functions, including discovery research, clinical development, pharmacovigilance and regulatory affairs.
In her current role as EMEA Policy Lead, Alison leads Janssen engagement in healthcare regulatory policy activities, through health authority interactions, consultation, trade association and other collaborative initiatives.
Alison has been actively involved with TransCelerate for several years, initially as regulatory co-lead for the eConsent initiative and currently on the Patient Technology initiative. Alison also sits on the TransCelerate Regulatory Council and currently holds the position of liaison to the European Medicines Agency.